NovaScan’s Les Bogdanowicz Invited to Present Results at CHEST Annual Meeting
NovaScan, an emerging oncology company based in Chicago, announced that CTO Les Bogdanowicz, PhD has been invited to present the results from a recent study at CHEST Annual Conference, held from October 16-19, in Nashville TN. Dr Bogdanowicz will discuss the results...
Dr Amit Mehta to Advise NovaScan
Dr Amit Mehta to Advise NovaScan on Ex Vivo Scanning Product NovaScan, an emerging oncology company based in Chicago, has announced that Dr Amit Mehta will guide NovaScan on the development of its ex vivo offerings for both gastroenterology and pulmonology. Dr Mehta...
WiSys names NovaScan leaders Craig Davis and William Gregory 2022 Innovators of the Year
NovaScan's CEO Craig Davis and founder Dr. William Gregory were honored as Carl E. Gulbrandsen Innovators of the Year at the WiSys SPARK Symposium. The award recognizes those making significant innovations within the UW System. The awards were presented at WiSys SPARK...
NovaScan announces Luminary Scientific Advisory Board Leaders in Pulmonary and Gastroenterology
Chicago IL: NovaScan, a clinical-stage oncology company based in Chicago, has announced the appointment of a luminaries in gastroeneterology to lead initiatives in GI. NovaScan’s gastroenterology Scientific Advisory Board will be led by Dr Isaac Raijman, AGAF, FASGE,...
NovaScan Lung Studies Published in a Leading Peer Reviewed Journal
NovaScan, a clinical-stage oncology company based in Chicago and Milwaukee, recently had its publication titled "The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and ex vivo Patient Studies" accepted in the highly...
NovaScan Completes $8MM Series B Financing
CHICAGO, IL, USA, November 17, 2021 /EINPresswire.com/ -- NovaScan, a clinical stage oncology company pioneering a new low cost point of care platform for cancer detection and treatment, announced that it has completed a $8 Million Series B financing, led by Builders...
NovaScan Fully Subscribes and Completes $3MM Financing
NovaScan, an emerging oncology company based in Chicago and Milwaukee, has announced that it has completed a $3MM financing. The convertible note financing was originally targeted for $2MM, but demand exceeded that amount and the company opportunistically added...
NovaScan Study on Cancer Recurrence and the Cole Frequency Published in a Peer-Reviewed Journal
NovaScan, a clinical stage oncology company based in Chicago and Milwaukee, recently had its publication titled Cole Relaxation Frequency as a Prognostic Parameter for Breast Cancer accepted in a peer-reviewed journal, the Journal of Patient Centered Research and...